Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD

Clinical trial NCT04993352 · COMPLETED

Trial details

NCT number: NCT04993352
Sponsor: Shanghai Henlius Biotech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Age Related Macular Degeneration

Start date: 2021-07-15
Primary completion: 2022-07-07
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.